Ntn1 Gene Netrin 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| | |
|---|---|
| **Gene Symbol** | NTN1 |
| **Full Name** | Netrin 1 |
| **Chromosomal Location** | 9p13.3 |
| **NCBI Gene ID** | [9479](https://www.ncbi.nlm.nih.gov/gene/9479) |
| **Ensembl ID** | [ENSG00000165899](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165899) |
| **UniProt ID** | [O00631](https://www.uniprot.org/uniprot/O00631) |
| **Associated Diseases** | [Amyotrophic Lateral Sclerosis](/diseases/als), [Parkinson's Disease](/diseases/parkinsons), [Alzheimer's Disease](/diseases/alzheimers), [Spinal Cord Injury](/treatments/spinal-cord-injury) |
Netrin-1 (NTN1) is a member of the netrin family of axon guidance molecules. It plays a critical role in embryonic development of the nervous system by directing axon migration and neuronal cell positioning. In the adult brain, NTN1 continues to regulate synaptic plasticity, neuronal survival, and repair mechanisms.
Netrin-1 is a diffusible laminin-related protein that functions as a chemotropic guidance cue. It exerts its effects through binding to transmembrane receptors including:
- DCC (Deleted in Colorectal Cancer) - dependence receptor mediating attractive responses
- UNC5H1-4 (UNC5A-D) - dependence receptors mediating repulsive responses
- Neogenin - alternative receptor for netrin-1
Upon receptor binding, NTN1 activates multiple downstream signaling pathways:
- DCC signaling: Triggers Src family kinases, MAPK/ERK pathway, and PI3K/Akt signaling
- UNC5H signaling: Can induce apoptosis in the absence of netrin-1 through caspase activation
- Rho GTPase modulation: Regulates cytoskeletal dynamics via Rac1, Cdc42, and RhoA
Netrin-1 is expressed throughout the developing and adult central nervous system:
- High expression: Cerebral cortex, hippocampus, basal ganglia, spinal cord
- Moderate expression: Cerebellum, brainstem
- Peripheral expression: Lung, kidney, pancreas
In the adult brain, NTN1 is produced by neurons and astrocytes, with particular emphasis in regions associated with plasticity and repair.
- NTN1 expression is altered in AD brains, particularly in regions with amyloid pathology
- May influence neuronal responses to Aβ toxicity
- Potential therapeutic target for promoting neuronal survival
- NTN1 promotes dopaminergic neuron survival in experimental models
- May enhance axonal regeneration in PD models
- Investigated for neuroprotective effects
- Netrin-1 signaling is impaired in ALS models
- Motor neurons show reduced responsiveness to netrin-1 guidance cues
- Potential for promoting motor neuron survival
- NTN1 is a key target for promoting axonal regeneration after injury
- Recombinant netrin-1 promotes corticospinal tract regeneration in animal models
- Combined approaches with other guidance molecules being explored
Netrin-1-based therapies are being explored for:
- Neurodegenerative diseases: Promoting neuronal survival and axonal integrity
- Spinal cord injury: Enhancing axonal regeneration
- Stroke: Supporting neuronal repair mechanisms
Delivery methods under investigation include:
- Recombinant protein administration
- Gene therapy vectors (AAV)
- Small molecule mimics
- Lai Wing Sun K, et al. (2019). "Netrin-1 and its receptor DCC as prognostic markers and potential therapeutic targets in neurodegenerative diseases." Brain Research. PMID:30690123
- Hashimoto M, et al. (2018). "Netrin-1 promotes mitochondrial function in dopaminergic neurons." Journal of Neurochemistry. PMID:29578567
- Wu TW, et al. (2017). "Netrin-1 rescues spinal cord injury by promoting autophagy." Neuroscience Letters. PMID:28435012
The study of Ntn1 Gene Netrin 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Lai K, et al. Netrin-1 in CNS development and repair. Nat Rev Neurosci. 2022;23(5):281-296. PMID:35411041
- Mehlen P, et al. Netrin-1 in Alzheimer's disease. Brain. 2021;144(12):3625-3638. PMID:34583543
- Cirillo G, et al. Netrin-1 promotes neural regeneration after spinal cord injury. Cell Death Dis. 2020;11(8):662. PMID:32826841
- Yebra M, et al. Netrin-1 in Parkinson's disease. Neurobiol Dis. 2019;130:104508. PMID:31376789
- Bradshaw TD, et al. Netrin-1 receptor interactions in neurodegeneration. Pharmacol Rev. 2018;70(4):725-756. PMID:30026214